Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials
Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and tissue scarring, and leading to impaired lung function and respiratory failure. Although current treatments, such as pirfenidone and nintedanib, slow disease progression,...
Saved in:
| Main Authors: | Jinsha Liu, Zifeng Pan, Arshma Khan, Haoguang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-04-01
|
| Series: | BIO Integration |
| Subjects: | |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary fibrosis: from mechanisms to therapies
by: Mengna Jiang, et al.
Published: (2025-05-01) -
Nanogene editing drug delivery systems in the treatment of liver fibrosis
by: Qun Wang, et al.
Published: (2024-09-01) -
Emerging biomaterials and bio-nano interfaces in pulmonary hypertension therapy: transformative strategies for personalized treatment
by: Xiaofa Chen, et al.
Published: (2025-05-01) -
Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy
by: Shu Zhang, et al.
Published: (2025-06-01) -
Multifunctional nanoparticle platform for targeted delivery and vaccines
by: Anja S. Redecker, et al.
Published: (2025-06-01)